China SXT Pharmaceuticals (STU:2RY1) FFO


STU:2RY1 China SXT Pharmaceuticals Inc STU:2RY1
27 GF Score
Price €384.00
GF Value €321.31
! 7 Warning Signs
View Full Analysis

What is China SXT Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

STU:2RY1
27GF Score
China SXT Pharmaceuticals Inc STU:2RY1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China SXT Pharmaceuticals (STU:2RY1) Overvalued in 2026?

Based on GuruFocus' analysis, China SXT Pharmaceuticals stock appears to be overvalued. The current stock price of €384.00 is trading 19.5% above its estimated GF Value™ of €321.31.

Key valuation signals for STU:2RY1:

  • FFO:
  • GF Value™: €321.31 vs. price of €384.00 (19.5% above fair value)
  • GF Score™: 27/100 with 7 warning signs

No single metric tells the full story. See the STU:2RY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China SXT Pharmaceuticals Business Description

Other Exchanges SXTC:USA
Address No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
27GF Score

Get the complete analysis for STU:2RY1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€384.00
Price
€321.31
GF Value